What is 3D Biotek?
Headquartered in New Jersey, 3D Biotek operates at the intersection of high-tech engineering and life sciences. The company specializes in the development of sophisticated 3-dimensional cell culture devices, utilizing proprietary Precision 3D Micro-Fabrication Technology. By providing high-quality tools for stem cell research, tissue engineering, and drug discovery, 3D Biotek serves as a critical partner for laboratories and pharmaceutical entities. Their business model is dual-faceted, combining the production of specialized hardware with comprehensive contract lab and manufacturing services, which allows them to address the complex requirements of modern cell biology research.
How much funding has 3D Biotek raised?
3D Biotek has raised a total of $49K across 1 funding round:
Debt
$49K
Debt (2021): $49K with participation from PPP
Key Investors in 3D Biotek
PPP
Public-Private Partnership
What's next for 3D Biotek?
With the recent infusion of capital, 3D Biotek is expected to scale its manufacturing capabilities and broaden its reach in the global drug discovery market. The strategic focus will likely shift toward optimizing their bio-manufacturing workflows and expanding their portfolio of 3D cell culture products to meet the rising demand for more accurate, physiologically relevant research models. As the company transitions through this growth phase, the emphasis will remain on maintaining technical superiority in micro-fabrication while scaling operations to support larger-scale commercial partnerships and long-term innovation in regenerative medicine.
See full 3D Biotek company page
